HEATH E SCOTT
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- YAZOO CITY, MS
- NPI
- 1205881489
- Received
- $1,130 in 65 records, 2019 to 2025
- As principal investigator
- $65,388 of research payments to others in 4 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 19 | $386 |
| 2024 | General payment | 11 | $218 |
| 2023 | General payment | 3 | $46 |
| 2022 | General payment | 13 | $211 |
| 2021 | General payment | 14 | $202 |
| 2020 | General payment | 2 | $26 |
| 2019 | General payment | 3 | $38 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Abbott Laboratories | 12 | $209 | 2021–2025 |
| PFIZER INC. | 5 | $105 | 2023–2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90 | 2020–2025 |
| Janssen Pharmaceuticals, Inc | 6 | $84 | 2021–2022 |
| Amgen Inc. | 4 | $79 | 2025 |
| Teva Pharmaceuticals USA, Inc. | 3 | $72 | 2025 |
| Lilly USA, LLC | 3 | $61 | 2024–2025 |
| ABBVIE INC. | 3 | $59 | 2019–2024 |
| Lundbeck LLC | 3 | $52 | 2023–2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $50 | 2020–2021 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 | 2021 |
| Novo Nordisk Inc | 2 | $29 | 2022–2024 |
| GlaxoSmithKline, LLC. | 2 | $26 | 2022–2025 |
| Mylan Specialty L.P. | 1 | $24 | 2024 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 | 2024 |
| Exact Sciences Corporation | 1 | $19 | 2024 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 | 2025 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 | 2024 |
| Merck Sharp & Dohme LLC | 1 | $14 | 2021 |
| E.R. Squibb & Sons, L.L.C. | 1 | $13 | 2021 |
| Hikma Pharmaceuticals USA | 1 | $12 | 2022 |
| SANOFI PASTEUR INC. | 1 | $12 | 2019 |
| GRT US Holding, Inc. | 1 | $11 | 2022 |
| Boston Scientific Corporation | 1 | $10 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 64 | $1,115 |
| Education | 1 | $14 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-10-30 | Teva Pharmaceuticals USA, Inc. | $31 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-28 | Lundbeck LLC | $23 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-14 | Lilly USA, LLC | $23 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-10-07 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-09-16 | Lundbeck LLC | $16 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-04 | Amgen Inc. | $27 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-08-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | $13 | Food and Beverage (2 payments) | In-kind items and services | 2025 | ||
| 2025-08-12 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-07-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | $17 | Food and Beverage (2 payments) | In-kind items and services | 2025 | ||
| 2025-07-24 | PFIZER INC. | $26 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-01 | Teva Pharmaceuticals USA, Inc. | $19 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-06-03 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-05-29 | PFIZER INC. | $25 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-03-18 | Amgen Inc. | $13 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-03-13 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-03-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-07 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-01-23 | Abbott Laboratories | $20 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-01-23 | Abbott Laboratories | $15 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2024-12-10 | Mylan Specialty L.P. | $24 | Food and Beverage | In-kind items and services | YUPELRI Drug, Anticholinergics, Inhaled | 2024 | |
| 2024-12-03 | Abbott Laboratories | $22 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2024 | |
| 2024-10-25 | Abbott Laboratories | $14 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2024 | |
| 2024-10-08 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-19 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-06 | Phathom Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-24 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-07-18 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-05-28 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-03-26 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-01-30 | Exact Sciences Corporation | $19 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2024 | |
| 2023-09-07 | Lundbeck LLC | $12 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-08-24 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | PAXLOVID Drug, INFECTIOUS DISEASES | 2023 | |
| 2023-04-20 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2023 | |
| 2022-12-15 | Boehringer Ingelheim Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-12-14 | Abbott Laboratories | $13 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE Device, Diabetes Care | 2022 | |
| 2022-12-06 | GlaxoSmithKline, LLC. | $12 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2022 | |
| 2022-11-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | $27 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-10-25 | GRT US Holding, Inc. | $11 | Food and Beverage | In-kind items and services | Qutenza Drug, Pain Management | 2022 | |
| 2022-10-18 | Abbott Laboratories | $18 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-10-18 | Abbott Laboratories | $15 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-07-27 | Abbott Laboratories | $17 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-07-20 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-07-13 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2022 | |
| 2022-06-08 | Abbott Laboratories | $18 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-04-19 | Hikma Pharmaceuticals USA | $12 | Food and Beverage | In-kind items and services | Mitigare Drug, Cardiology/Vascular Diseases | 2022 | |
| 2022-02-22 | Janssen Pharmaceuticals, Inc | $19 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2022 | |
| 2021-11-23 | Abbott Laboratories | $17 | Food and Beverage | In-kind items and services | FreeStyle Libre 2 Device, Diabetes Care | 2021 | |
| 2021-11-02 | Abbott Laboratories | $16 | Food and Beverage | In-kind items and services | FreeStyle Libre 2 Device, Diabetes Care | 2021 | |
| 2021-09-22 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2021 | |
| 2021-09-15 | Merck Sharp & Dohme LLC | $14 | Food and Beverage | In-kind items and services | BELSOMRA Drug, NEUROSCIENCE | 2021 | |
| 2021-08-30 | Abbott Laboratories | $19 | Food and Beverage | In-kind items and services | FreeStyle Libre 2 Device, Diabetes Care | 2021 | |
| 2021-07-27 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2021 | |
| 2021-06-29 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2021 | |
| 2021-06-16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2021 | |
| 2021-06-08 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2021 | |
| 2021-06-02 | AstraZeneca Pharmaceuticals LP | $11 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2021 | |
| 2021-05-19 | E.R. Squibb & Sons, L.L.C. | $13 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2021 | |
| 2021-05-13 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2021 | |
| 2021-05-04 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2021 | |
| 2021-04-06 | Janssen Pharmaceuticals, Inc | $12 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2021 | |
| 2020-02-28 | Boehringer Ingelheim Pharmaceuticals, Inc. | $14 | Education | In-kind items and services | SPIRIVA RESPIMAT Drug, RESPIRATORY | 2020 | |
| 2020-02-12 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12 | Food and Beverage | In-kind items and services | XIFAXAN Drug, GASTROENTEROLOGY | 2020 | |
| 2019-05-09 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-03-13 | Boston Scientific Corporation | $10 | Food and Beverage | In-kind items and services | GENERAL THERAPIES Device, THERAPIES | 2019 | |
| 2019-01-17 | SANOFI PASTEUR INC. | $12 | Food and Beverage | In-kind items and services | FLUZONE HIGH-DOSE Drug, VACCINES | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-03-31 | Novartis Pharmaceuticals Corporation | YAZOO CLINICAL RESEARCH | $159 | Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Car | 2025 |
| 2024-01-30 | Novartis Pharmaceuticals Corporation | YAZOO CLINICAL RESEARCH | $43,966 | Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Car | 2024 |
| 2024-01-15 | Novartis Pharmaceuticals Corporation | YAZOO CLINICAL RESEARCH | $4,732 | A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With T | 2024 |
| 2023-01-26 | Novartis Pharmaceuticals Corporation | YAZOO CLINICAL RESEARCH | $16,530 | A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With T | 2023 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Yazoo City, MS, county Yazoo County, MS, state Mississippi; placed by its city name.
| Measure | Place (city or town) Yazoo City, MS | County Yazoo County, MS | State Mississippi |
|---|---|---|---|
| Population B01003 | 10,219 | 24,835 | 2,946,779 |
| Population, 2020 census P1 | 10,316 | 26,743 | 2,961,279 |
| Median age B01002 | 34.0 | 38.6 | 38.6 |
| Under 18 B01001 | 29.8% | 22.9% | 23.3% |
| 65 and over B01001 | 15.6% | 15.2% | 17.2% |
| Households B11001 | 4,000 | 8,767 | 1,145,431 |
| Foreign born B05002 | 0.1% | 3.8% | 2.4% |
| Median household income B19013 | $28,157 | $39,295 | $56,447 |
| Median family income B19113 | $38,669 | $56,949 | $73,163 |
| Per capita income B19301 | $20,902 | $21,862 | $31,549 |
| Poverty rate B17001 | 46.7% | 30.8% | 18.9% |
| Unemployment rate B23025 | 12.7% | 9.7% | 5.8% |
| Civilian labor force B23025 | 3,783 | 8,465 | 1,332,121 |
| Mean commute (minutes) B08013 | 22.1 | 25.8 | 25.6 |
| Bachelor's degree or higher B15003 | 13.4% | 15.3% | 25.1% |
| Housing units B25001 | 4,865 | 10,485 | 1,341,114 |
| Owner-occupied B25003 | 33.0% | 55.3% | 70.0% |
| Renters B25003 | 67.0% | 44.7% | 30.0% |
| Median home value B25077 | $103,000 | $153,800 | $169,800 |
| Median gross rent B25064 | $767 | $790 | $954 |
| White, not Hispanic B03002 | 9.7% | 35.9% | 55.2% |
| Black B03002 | 88.6% | 57.1% | 36.3% |
| Hispanic or Latino B03002 | 0.5% | 5.4% | 3.7% |
| Asian B03002 | 0.0% | 0.1% | 1.0% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.4% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Yazoo City, MS.
Comments